Interchange Capital Partners, LLC Natera, Inc. Transaction History

Interchange Capital Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	BUY	$132.23 - $171.87 $176,791 - $229,790	1,337 Added 439.8%	1,641 $277,000
Q2 2025 Jul 28, 2025	SELL	$132.23 - $171.87 $176,130 - $228,930	-1,332 Reduced 81.42%	304 $51,000
Q1 2025 Apr 29, 2025	SELL	$132.63 - $177.0 $21,220 - $28,320	-160 Reduced 8.91%	1,636 $231,000
Q4 2024 Feb 11, 2025	BUY	$117.67 - $174.0 $5,648 - $8,352	48 Added 2.75%	1,796 $284,000
Q3 2024 Oct 28, 2024	BUY	$97.75 - $129.67 $170,867 - $226,663	1,748 New	1,748 $222,000

753

127M

1.13M

449K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $19.8B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Interchange Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Interchange Capital Partners, LLC with notifications on news.